Immunological Medicines for Pigs
Immunological veterinary medicinal products, including vaccines, are authorised for pigs.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Cirbloc M Hyo
|
Circovirus-Infektion, Enzootische Pneumonie
|
Ceva-Phylaxia Co. Ltd., Ungarn
|
EU/2/24/322 |
25.10.2024 |
Schwein |
EPAR: Cirbloc M Hyo
|
Ingelvac Aujeszky MLV plus
|
Aujeszky'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
320a/93 |
19.07.1997 |
Schwein |
PharmNet.Bund
|
Ingelvac PRRS MLV
|
PRRS
|
Boehringer Ingelheim Vetmedica GmbH
|
143a/97 |
15.07.1999 |
Schwein |
PharmNet.Bund
|
ReproCyc ParvoFLEX
|
Parvovirose
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/19/237 |
26.04.2019 |
Schwein |
EPAR: ReproCyc ParvoFLEX
|
ReproCyc PRRS EU
|
PRRS
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.11723.01.1 |
24.03.2015 |
Schwein |
PharmNet.Bund
|
Ingelvac CircoFLEX
|
Circovirus-Infektion
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/07/079/001-004 |
13.02.2008 |
Schwein |
EPAR: Ingelvac CircoFLEX
|
Ingelvac MycoFLEX Injektionssuspension
|
Enzootische Pneumonie
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.04758.01.1 |
12.05.2009 |
Schwein |
PharmNet.Bund
|
Ingelvac PRRSFLEX EU
|
PRRS
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.11722.01.1 |
19.03.2015 |
Schwein |
PharmNet.Bund
|
Enterisol Ileitis
|
Lawsonia intracellularis-Infektion
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.02996.01.1 |
28.10.2004 |
Schwein |
PharmNet.Bund
|
Suigen Entero 3
|
E. coli-Infektion, Rotavirus-Infektion, Clostridien-Infektion
|
Bioveta a.s., Tschechien
|
PEI.V.12174.01.1 |
29.04.2024 |
Schwein |
PharmNet.Bund
|
Brucellin Aquilón
|
Hauttest zur Diagnose einer Brucella-Infektion
|
Aquilón Cyl S.L., Spanien
|
EU/2/22/291/001 |
26.01.2023 |
Schwein |
EPAR: Brucellin Aquilón
|
Gletvax 6
|
E. coli-Infektion,
Nekrotisierende Enteritis der Ferkel
|
Zoetis Deutschland GmbH
|
254a/94 |
30.06.1998 |
Schwein |
PharmNet.Bund
|
Parvoruvac
|
Rotlauf,
Parvovirose
|
Ceva Tiergesundheit GmbH
|
490a/87 |
23.11.2005 |
Schwein |
PharmNet.Bund
|
ECOPORC SHIGA
|
E. coli-Infektion, Enterotoxämie (Ödemkrankheit)
|
CEVA Santé Animale
|
EU/2/13/149/001-002 |
10.04.2013 |
Schwein |
EPAR: ECOPORC SHIGA
|
SALMOPORC
|
Salmonellen-Infektion
|
Ceva Tiergesundheit GmbH
|
PEI.V.02340.01.1 |
25.07.2002 |
Schwein |
PharmNet.Bund
|
Coglapix
|
Actinobazillus pleuropneumonie
|
Ceva Tiergesundheit GmbH
|
PEI.V.11731.01.1 |
12.10.2015 |
Schwein |
PharmNet.Bund
|
Progressis
|
PRRS
|
Ceva Tiergesundheit GmbH
|
PEI.V.01709.01.1 |
28.11.2000 |
Schwein, Jungsau, Zuchtsau |
PharmNet.Bund
|
BIOSUIS ParvoEry
|
Rotlauf, Parvovirose
|
Bioveta, a.s., Tschechien
|
PEI.V.12091.01.1 |
23.06.2021 |
Schwein |
PharmNet.Bund
|
RESPIPORC FLUpan H1N1
|
Schweineinfluenza
|
CEVA Santé Animale
|
EU/2/17/209/001-002 |
17.05.2017 |
Schwein |
EPAR: Respiporc Flupan H1N1
|
M+PAC
|
Enzootische Pneumonie
|
Intervet Deutschland GmbH
|
PEI.V.03209.01.1 |
23.12.2004 |
Schwein, Mastschwein |
PharmNet.Bund
|
Suvaxyn MH-One
|
Enzootische Pneumonie
|
Zoetis Deutschland GmbH
|
PEI.V.02689.01.1 |
01.04.2005 |
Schwein, Mastschwein |
PharmNet.Bund
|
Hyogen
|
Enzootische-Pneumonie
|
Ceva Tiergesundheit GmbH
|
PEI.V.11714.01.1 |
08.05.2015 |
Schwein |
PharmNet.Bund
|
Porcilis Lawsonia
|
Lawsonia intracellularis-Infektion
|
Intervet Deutschland GmbH
|
PEI.V.11983.01.1 |
19.09.2019 |
Schwein |
PharmNet.Bund
|
RESPIPORC Flu 3
|
Schweineinfluenza
|
CEVA Santé Animale
|
EU/2/09/103/001-006 |
14.01.2010 |
Schwein |
EPAR: Respiporc Flu 3
|
Zylexis
|
Paramunisierung, Stimulierung unspezifischer Immunmechanismen
|
Zoetis Deutschland GmbH
|
PEI.V.02388.01.1 |
05.11.2001 |
Hund, Katze, Pferd, Rind, Schwein |
PharmNet.Bund
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 529 in BAnz AT 30.05.2025 B6.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.